D. Malcolm Duckworth

890 citations

19 papers · 611 indexed · h-index 12

Molecular Biology
Cellular and Molecular Neuroscience top 5%
Organic Chemistry top 10%
Physiology
Computational Theory and Mathematics top 10%

Co-authors: Frank D. King Steven Dabbs Ian T. Forbes Graham J. Riley Derek N. Middlemiss Jim J. Hagan A.J. Jennings David R. Thomas
Topics: Pharmacological Receptor Mechanisms and Effects (3 papers)Receptor Mechanisms and Signaling (3 papers)Chemical synthesis and alkaloids (3 papers)
Cited by: Cellular and Molecular Neuroscience Molecular Biology Organic Chemistry
Journals: The Journal of Physiology Brain Research Journal of Medicinal Chemistry
Partner nations: United Kingdom United States France

In The Last Decade

D. Malcolm Duckworth

19 papers receiving 578 citations

Peers

Countries citing papers authored by D. Malcolm Duckworth

Since Specialization

Citations

This map shows the geographic impact of D. Malcolm Duckworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Malcolm Duckworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Malcolm Duckworth more than expected).

Fields of papers citing papers by D. Malcolm Duckworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Malcolm Duckworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Malcolm Duckworth. The network helps show where D. Malcolm Duckworth may publish in the future.

Co-authorship network of co-authors of D. Malcolm Duckworth

This figure shows the co-authorship network connecting the top 25 collaborators of D. Malcolm Duckworth. A scholar is included among the top collaborators of D. Malcolm Duckworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Malcolm Duckworth. D. Malcolm Duckworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	In silico identification of novel therapeutic targets 2002 ·Drug Discovery Today ·D. Malcolm Duckworth,Philippe Sanséau	10
2	Kinetic modification of the α_1I subunit‐mediated T‐type Ca²⁺ channel by a human neuronal Ca²⁺ channel γ subunit 2001 ·The Journal of Physiology ·(unknown),Ruth Warre,Philip D. Hayes,(unknown),Andrew D. Medhurst,Menelas N. Pangalos,D. Malcolm Duckworth,Andrew D. Randall	33
3	The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK 2001 ·Brain Research ·H.J. Meadows,C.G. Chapman,D. Malcolm Duckworth,Rosemary E. Kelsell,Paul R. Murdock,S. Nasir,(unknown),Andrew D. Randall	47
4	1-[2-[(Heteroaryloxy)heteroaryl]carbamoyl]indolines: novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/Anxiolytic agents 2000 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge,Steven Dabbs,Susannah Davies,D. Malcolm Duckworth,Ian T. Forbes,Graham E. Jones,(unknown),Frank D. King,(unknown),Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Sean Lightowler,Derek N. Middlemiss,Graham J. Riley,Brenda Trail,Martyn Wood	16
5	The Impact of Genomics on Drug Discovery 2000 ·Progress in medicinal chemistry ·Lee J. Beeley,D. Malcolm Duckworth,Christopher Southan	11
6	1-[2-[(Heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orally active 5-HT2C receptor inverse agonists 2000 ·Bioorganic & Medicinal Chemistry Letters ·Steven M. Bromidge,Susannah Davies,D. Malcolm Duckworth,Ian T. Forbes,Graham E. Jones,(unknown),Frank D. King,Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Sean Lightowler,Derek N. Middlemiss,Graham J. Riley,Brenda Trail,Martyn Wood	10
7	A Novel, Potent, and Selective 5-HT₇Antagonist: (R)-3-(2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970) 2000 ·Journal of Medicinal Chemistry ·Peter J. Lovell,Steven M. Bromidge,Steven Dabbs,D. Malcolm Duckworth,Ian T. Forbes,A.J. Jennings,Frank D. King,Derek N. Middlemiss,Shirley K. Rahman,(unknown),(unknown),Jim J. Hagan,Graham J. Riley,David R. Thomas	227
8	Model studies on a synthetically facile series of N-substituted phenyl-N′-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists 1999 ·Bioorganic & Medicinal Chemistry ·Steven M. Bromidge,Steven Dabbs,David T. Davies,Susannah Davies,D. Malcolm Duckworth,Ian T. Forbes,(unknown),P. J. Ham,Graham E. Jones,(unknown),(unknown),Kevin M. Thewlis,Dolatrai M. Vyas,Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Graham J. Riley,Martyn Wood	5
9	Novel and Selective 5-HT_2C/2B Receptor Antagonists as Potential Anxiolytic Agents: Synthesis, Quantitative Structure−Activity Relationships, and Molecular Modeling of Substituted 1-(3-Pyridylcarbamoyl)indolines 1998 ·Journal of Medicinal Chemistry ·Steven M. Bromidge,Steven Dabbs,David T. Davies,D. Malcolm Duckworth,Ian T. Forbes,P. J. Ham,Graham E. Jones,Frank D. King,(unknown),(unknown),Kevin M. Thewlis,Paul Wyman,Frank E. Blaney,Christopher Naylor,Fiona P. Bailey,Thomas P. Blackburn,Vicky Holland,G.A. Kennett,Graham J. Riley,Martyn Wood	53
10	(R)-3,N-Dimethyl-N-[1-methyl-3-(4-methylpiperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT₇Receptor Antagonist 1998 ·Journal of Medicinal Chemistry ·Ian T. Forbes,Steven Dabbs,D. Malcolm Duckworth,A.J. Jennings,Frank D. King,Peter J. Lovell,Anthony M. Brown,(unknown),Jim J. Hagan,Derek N. Middlemiss,Graham J. Riley,David R. Thomas,Neil Upton	86
11	ChemInform Abstract: Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5‐HT2C/2B Receptor Antagonists. 1997 ·ChemInform ·Ian T. Forbes,Steven Dabbs,D. Malcolm Duckworth,P. J. Ham,Gareth E. Jones,Frank D. King,(unknown),Frank E. Blaney,Christopher Naylor,Gordon S. Baxter,Thomas P. Blackburn,G.A. Kennett,Martyn Wood	1
12	The impact of genomics on drug design 1996 ·Drug Discovery Today ·Lee J. Beeley,D. Malcolm Duckworth	9
13	Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists 1996 ·Journal of Medicinal Chemistry ·Ian T. Forbes,Steven Dabbs,D. Malcolm Duckworth,P. J. Ham,Graham E. Jones,Frank D. King,(unknown),Frank E. Blaney,Christopher Naylor,Gordon S. Baxter,Thomas P. Blackburn,G.A. Kennett,Martyn Wood	23
14	Co-cyclizations of nitrogen-containing acetylenes induced by a nickel triphenylphosphine complex to give aminoindane, isoindoline and isoindolinone derivatives 1996 ·Journal of the Chemical Society Perkin Transactions 1 ·D. Malcolm Duckworth,(unknown),Alexandra M. Z. Slawin,Edward H. Smith,David J. Williams	18
15	9-[2-(Phosphonomethoxy)alkoxy]purines, A New Series of Antiviral Acyclonucleotides 1991 ·Nucleosides and Nucleotides ·D. Malcolm Duckworth,M. R. HARNDEN,Robert M. Perkins,D. N. Planterose	10
16	Biogenetically patterned synthesis of cadambine 1991 ·Tetrahedron Letters ·Richard T. Brown,D. Malcolm Duckworth,Cid Aimbiré de Moraes Santos	20
17	Antiviral 9-[2-(phosphonomethoxy)alkoxy]purines 1991 ·Antiviral chemistry & chemotherapy ·D. Malcolm Duckworth,M. R. HARNDEN,Robert M. Perkins,D. N. Planterose	17
18	C-20 configuration in adirubine 1976 ·Journal of the Chemical Society Chemical Communications ·Richard T. Brown,D. Malcolm Duckworth	1
19	Conversion of secologanin into elenolic acid and 18-oxayohimban alkaloids 1976 ·Journal of the Chemical Society Perkin Transactions 1 ·Richard T. Brown,(unknown),D. Malcolm Duckworth,(unknown)	14

About D. Malcolm Duckworth

D. Malcolm Duckworth is a scholar working on Pharmacology, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 19 papers that have together received 611 indexed citations. Recurring topics across this work include Pharmacological Receptor Mechanisms and Effects (3 papers), Receptor Mechanisms and Signaling (3 papers) and Chemical synthesis and alkaloids (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (316 citations), Molecular Biology (378 citations) and Organic Chemistry (151 citations). D. Malcolm Duckworth has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Frank D. King, Steven Dabbs, Ian T. Forbes, Graham J. Riley, Derek N. Middlemiss, Jim J. Hagan, A.J. Jennings, David R. Thomas, Peter J. Lovell and Steven M. Bromidge. Their work appears in journals such as The Journal of Physiology, Brain Research and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact